Urology
Volume 58, Issue 2 , Pages 262-266 , August 2001

Analysis of the consistency of intraurethral prostaglandin E1 (MUSE) during at-home use

  • John P Mulhall

      Affiliations

    • Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA
    • Corresponding Author InformationReprint requests: John P. Mulhall, M.D., Department of Urology, Loyola University Medical Center, Stritch School of Medicine, 2160 South 1st Avenue, Maywood, IL 60304
    • ,
  • Andrew E Jahoda

      Affiliations

    • Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA
    • ,
  • Absaar Ahmed

      Affiliations

    • Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA
    • ,
  • Marilyn Parker

      Affiliations

    • Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA

Received 31 January 2001 ,Revised 4 April 2001 ,Accepted 4 April 2001.

References 

  1. Feldman HAGI, Hatzichristou DG, Krane RJ, et al.  Impotence and its medical and psychosocial correlates (results of the Massachusetts Male Aging Study). J Urol. 1994;151:54–57
  2. Laumann EO, Paik A, Rosen RC. The epidemiology of erectile dysfunction (results from the National Health and Social Life Survey). Int J Impot Res. 1999;11(suppl 1):S60–S64
  3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States (prevalence and predictors). JAMA. 1999;281:537–544(published erratum appears in JAMA 281: 1174, 1999)
  4. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al, for the Medicated Urethral System for Erection (MUSE) Study Group: Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 336: 1–7, 1997.
  5. Porst H. Transurethral alprostadil administration with MUSE (current overview and personal experiences). Urologe A. 1998;37:410–416
  6. Costabile RA, Spevak M, Fishman IJ, et al.  Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol. 1998;160:1325–1328
  7. Engel JD, McVary KT. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. Urology. 1998;51:687–692
  8. Kim SC, Ahn TY, Choi HK, et al.  Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea. Int J Impot Res. 2000;12:97–101
  9. Porst H. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil—a comparative study in 103 patients with erectile dysfunction. Int J Impot Res. 1997;9:187–192
  10. Shokeir AA, Alserafi MA, Mutabagani H. Intracavernosal versus intraurethral alprostadil (a prospective randomized study). BJU Int. 1999;83:812–815
  11. Tam PY, Keller T, Poppiti R, et al.  Hemodynamic effects of transurethral alprostadil measured by color duplex ultrasonography in men with erectile dysfunction. J Urol. 1998;160:1321–1324
  12. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829–836
  13. Williams G, Abbou CC, Amar ET, et al, for the MUSE Study Group: The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. Br J Urol 82: 847–854, 1998.
  14. Williams G, Abbou CC, Amar ET, et al, for the MUSE Study Group: Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. Br J Urol 81: 889–894, 1998.
  15. Fallon B. Intracavernous injection therapy for male erectile dysfunction. Urol Clin North Am. 1995;22:833–845
  16. Werthman P, Rajfer J. MUSE therapy (preliminary clinical observations). Urology. 1997;50:809–811
  17. Mulhall JP, Jahoda A, Abobakr R, et al.  The causes of patient drop-out from a penile self-injection therapy for impotence. J Urol. 1999;158:1752–1759
  18. Rosen RC, Riley A, Wagner G, et al.  The International Index of Erectile Function (IIEF) (a multidimensional scale for assessment of erectile dysfunction). Urology. 1997;49:822–830
  19. Althof SE, Corty EW, Levine SB, et al.  EDITS (development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction). Urology. 1999;53:793–799
  20. Goldstein I, Lue TF, Padma-Nathan H, et al.  Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338:1397–1404

PII: S0090-4295(01)01164-5

Urology
Volume 58, Issue 2 , Pages 262-266 , August 2001

Article Tools

* Image Usage & Resolution